LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Ionis Pharmaceuticals, Inc. and Millions of Other Companies

Sign up for full access to Ionis Pharmaceuticals, Inc. information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Biopharma Partnerships Ionis Pharmaceuticals has established partnerships with prominent biopharmaceutical companies such as AstraZeneca, Biogen, and Bioragroup, indicating potential collaborative sales opportunities to leverage each other's resources and networks for market expansion.

Gene Editing Initiatives With recent collaborations with companies like Metagenomi, Ionis Pharmaceuticals is diving into gene editing technologies which opens up new avenues for sales of innovative treatments and therapies, allowing access to cutting-edge solutions for patients with serious diseases.

Market Expansion through Funding Ionis Pharmaceuticals secured significant funding through investments totaling $500 million and a successful public offering, enabling the company to fuel market expansion strategies that present new opportunities for sales growth and accelerated product development.

Priority Review for New Drug The acceptance of Ionis' FCS New Drug Application for Priority Review signifies an upcoming milestone that can be leveraged for sales efforts, presenting potential opportunities to position and market the new drug to address high patient needs effectively and quickly upon approval.

RNA Therapy Innovation As a pioneer in RNA-targeted medicines, Ionis Pharmaceuticals' innovative approaches highlight a unique selling point for the company's products, showcasing advanced therapies that can create avenues for sales differentiation and competitive advantage in the biotechnology market.

Similar companies to Ionis Pharmaceuticals, Inc.

✕

Access Insights for Ionis Pharmaceuticals, Inc. and Millions of Other Companies

Sign up for full access to Ionis Pharmaceuticals, Inc. information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ionis Pharmaceuticals, Inc. Tech Stack

Ionis Pharmaceuticals, Inc. uses 8 technology products and services including WordPress, MySQL, jQuery Migrate, and more. Explore Ionis Pharmaceuticals, Inc.'s tech stack below.

  • WordPress
    Content Management System
  • MySQL
    Database
  • jQuery Migrate
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • RSS
    Miscellaneous
  • Ubuntu
    Operating Systems
  • Apache HTTP Server
    Web Servers
  • Apache
    Web Servers

Media & News

Ionis Pharmaceuticals, Inc.'s Email Address Formats

Ionis Pharmaceuticals, Inc. uses at least 4 format(s):
Ionis Pharmaceuticals, Inc. Email FormatsExamplePercentage
FLast@ionispharma.comJDoe@ionispharma.com
93%
First@ionispharma.comJohn@ionispharma.com
5%
First.Last@ionispharma.comJohn.Doe@ionispharma.com
1%
LFirst@ionispharma.comDJohn@ionispharma.com
1%
FLast@ionisph.comJDoe@ionisph.com
98%
Last@ionisph.comDoe@ionisph.com
2%
FLast@isisph.comJDoe@isisph.com
88%
Last@isisph.comDoe@isisph.com
7%
First.Last@isisph.comJohn.Doe@isisph.com
3%
First_Last@isisph.comJohn_Doe@isisph.com
1%
FMiddleLast@isisph.comJMichaelDoe@isisph.com
1%
First@ionis.comJohn@ionis.com
100%

Frequently Asked Questions

Where is Ionis Pharmaceuticals, Inc.'s headquarters located?

Minus sign iconPlus sign iconIonis Pharmaceuticals, Inc.'s main headquarters is located at 2855 Gazelle Ct Carlsbad, CA 92010 US. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is Ionis Pharmaceuticals, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact Ionis Pharmaceuticals, Inc.'s main corporate office by phone at
✕

Access Insights for Ionis Pharmaceuticals, Inc. and Millions of Other Companies

Sign up for full access to Ionis Pharmaceuticals, Inc. information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-760-931-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Ionis Pharmaceuticals, Inc.'s stock symbol?

Minus sign iconPlus sign iconIonis Pharmaceuticals, Inc. is a publicly traded company; the company's stock symbol is IONS.

What is Ionis Pharmaceuticals, Inc.'s official website and social media links?

Minus sign iconPlus sign iconIonis Pharmaceuticals, Inc.'s official website is ionis.com and has social profiles on LinkedIn.

How much revenue does Ionis Pharmaceuticals, Inc. generate?

Minus sign iconPlus sign icon As of August 2024, Ionis Pharmaceuticals, Inc.'s annual revenue reached $750M.

What is Ionis Pharmaceuticals, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconIonis Pharmaceuticals, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ionis Pharmaceuticals, Inc. have currently?

Minus sign iconPlus sign iconAs of August 2024, Ionis Pharmaceuticals, Inc. has approximately 1.1K employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: B. P. M.Chief Business Officer: J. B.Chief Scientific Officer: F. B.. Explore Ionis Pharmaceuticals, Inc.'s employee directory with LeadIQ.

What industry does Ionis Pharmaceuticals, Inc. belong to?

Minus sign iconPlus sign iconIonis Pharmaceuticals, Inc. operates in the Biotechnology Research industry.

What technology does Ionis Pharmaceuticals, Inc. use?

Minus sign iconPlus sign iconIonis Pharmaceuticals, Inc.'s tech stack includes WordPressMySQLjQuery MigratejQueryRSSUbuntuApache HTTP ServerApache.

What is Ionis Pharmaceuticals, Inc.'s email format?

Minus sign iconPlus sign iconIonis Pharmaceuticals, Inc.'s email format typically follows the pattern of . Find more Ionis Pharmaceuticals, Inc. email formats with LeadIQ.

How much funding has Ionis Pharmaceuticals, Inc. raised to date?

Minus sign iconPlus sign icon As of August 2024, Ionis Pharmaceuticals, Inc. has raised $500M in funding. The last funding round occurred on Jun 06, 2023 for $500M.

When was Ionis Pharmaceuticals, Inc. founded?

Minus sign iconPlus sign iconIonis Pharmaceuticals, Inc. was founded in 1989.
Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.

Biotechnology ResearchCalifornia, United States1001-5000 Employees

For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients.

✕

Access Insights for Ionis Pharmaceuticals, Inc. and Millions of Other Companies

Sign up for full access to Ionis Pharmaceuticals, Inc. information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
2855 Gazelle Ct Carlsbad, CA 92010 US
Phone number
✕

Access Insights for Ionis Pharmaceuticals, Inc. and Millions of Other Companies

Sign up for full access to Ionis Pharmaceuticals, Inc. information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-760-931-****
Website
ionis.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
IONS
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1989
Employees
1001-5000

Section iconMedia & News

Section iconFunding & Financials

  • $500M

    Ionis Pharmaceuticals, Inc. has raised a total of $500M of funding over 3 rounds. Their latest funding round was raised on Jun 06, 2023 in the amount of $500M.

  • $100M$1B

    Ionis Pharmaceuticals, Inc.'s revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $500M

    Ionis Pharmaceuticals, Inc. has raised a total of $500M of funding over 3 rounds. Their latest funding round was raised on Jun 06, 2023 in the amount of $500M.

  • $100M$1B

    Ionis Pharmaceuticals, Inc.'s revenue is in the range of $100M$1B

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Ionis Pharmaceuticals, Inc. and Millions of Other Companies

Sign up for full access to Ionis Pharmaceuticals, Inc. information. No credit card needed.
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.